This topic contains a solution. Click here to go to the answer

Author Question: Extended-response performance-based assessments are better than restricted-response assessments ... (Read 63 times)

formula1

  • Hero Member
  • *****
  • Posts: 666
Extended-response performance-based assessments are better than restricted-response assessments under which of the following conditions?
 
  A. when the administration time is limited
  B. if a broad sampling of the domain of content is desired
  C. when a measure of the ability to gather and integrate information is needed
  D. if reliable scoring is of special importance

Question 2

Which of the following is a limitation of performance-based assessments?
 
  A. alignment to state standards
  B. ability to measure higher-order learning
  C. lengthy administration time
  D. the ability to assess all learners accurately



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

TheDev123

  • Sr. Member
  • ****
  • Posts: 332
Answer to Question 1

C

Answer to Question 2

C




formula1

  • Member
  • Posts: 666
Reply 2 on: Jun 20, 2018
YES! Correct, THANKS for helping me on my review


JCABRERA33

  • Member
  • Posts: 344
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

To combat osteoporosis, changes in lifestyle and diet are recommended. At-risk patients should include 1,200 to 1,500 mg of calcium daily either via dietary means or with supplements.

Did you know?

As the western states of America were settled, pioneers often had to drink rancid water from ponds and other sources. This often resulted in chronic diarrhea, causing many cases of dehydration and death that could have been avoided if clean water had been available.

Did you know?

HIV testing reach is still limited. An estimated 40% of people with HIV (more than 14 million) remain undiagnosed and do not know their infection status.

Did you know?

According to the FDA, adverse drug events harmed or killed approximately 1,200,000 people in the United States in the year 2015.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library